171 related articles for article (PubMed ID: 17139979)
21. Predictive Factors of Pelvic Lymph Node Metastasis in Early-Stage Cervical Cancer.
Nanthamongkolkul K; Hanprasertpong J
Oncol Res Treat; 2018; 41(4):194-198. PubMed ID: 29562222
[TBL] [Abstract][Full Text] [Related]
22. The number of pelvic lymph nodes in the quality control and prognosis of radical hysterectomy for the treatment of cervical cancer.
Pieterse QD; Kenter GG; Gaarenstroom KN; Peters AA; Willems SM; Fleuren GJ; Trimbos JB
Eur J Surg Oncol; 2007 Mar; 33(2):216-21. PubMed ID: 17097845
[TBL] [Abstract][Full Text] [Related]
23. High-risk group in node-positive patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation.
Aoki Y; Sasaki M; Watanabe M; Sato T; Tsuneki I; Aida H; Tanaka K
Gynecol Oncol; 2000 May; 77(2):305-9. PubMed ID: 10785483
[TBL] [Abstract][Full Text] [Related]
24. Surgical pathologic factors that predict recurrence in stage IB and IIA cervical carcinoma patients with negative pelvic lymph nodes.
Samlal RA; van der Velden J; Ten Kate FJ; Schilthuis MS; Hart AA; Lammes FB
Cancer; 1997 Oct; 80(7):1234-40. PubMed ID: 9317173
[TBL] [Abstract][Full Text] [Related]
25. Para-aortic lymph node involvement revisited in the light of the revised 2018 FIGO staging system for cervical cancer.
Ayhan A; Aslan K; Öz M; Tohma YA; Kuşçu E; Meydanli MM
Arch Gynecol Obstet; 2019 Sep; 300(3):675-682. PubMed ID: 31263988
[TBL] [Abstract][Full Text] [Related]
26. [Clinical analysis of 32 cases with neuroendocrine carcinoma of the uterine cervix in early-stage disease].
Wang Z; Wu L; Yao H; Sun Y; Li X; Li B; Zhang R; Ma S; Huang M
Zhonghua Fu Chan Ke Za Zhi; 2015 Mar; 50(3):198-203. PubMed ID: 26268410
[TBL] [Abstract][Full Text] [Related]
27. Influence of lymph vascular space invasion on prognosis of patients with early-stage cervical squamous cell carcinoma.
Yan M; Zhang YN; He JH; Sun JR; Sun XM
Chin J Cancer; 2010 Apr; 29(4):425-30. PubMed ID: 20346220
[TBL] [Abstract][Full Text] [Related]
28. Pelvic and parametrial lymph nodes in the quality control of the surgical treatment of cervical cancer.
Girardi F; Pickel H; Winter R
Gynecol Oncol; 1993 Sep; 50(3):330-3. PubMed ID: 8406196
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of histology and positive lymph node involvement following radical hysterectomy in carcinoma of the cervix.
Macdonald OK; Chen J; Dodson M; Lee CM; Gaffney DK
Am J Clin Oncol; 2009 Aug; 32(4):411-6. PubMed ID: 19451800
[TBL] [Abstract][Full Text] [Related]
30. Is there a place for a less extensive radical surgery in locally advanced cervical cancer patients?
Scambia G; Ferrandina G; Distefano M; Fagotti A; Manfredi R; Zannoni GF; Mancuso S
Gynecol Oncol; 2001 Nov; 83(2):319-24. PubMed ID: 11606092
[TBL] [Abstract][Full Text] [Related]
31. [Lymphatic mapping and parametrial lymph nodes identification in patients with early stage cervical cancer].
Li B; Wu LY; Li XG; Zhang X; Zhang WH; Gao JZ
Zhonghua Fu Chan Ke Za Zhi; 2006 Sep; 41(9):608-11. PubMed ID: 17181971
[TBL] [Abstract][Full Text] [Related]
32. Preoperative serum SCC, CA125, and CA19-9 levels and lymph node status in squamous cell carcinoma of the uterine cervix.
Takeda M; Sakuragi N; Okamoto K; Todo Y; Minobe S; Nomura E; Negishi H; Oikawa M; Yamamoto R; Fujimoto S
Acta Obstet Gynecol Scand; 2002 May; 81(5):451-7. PubMed ID: 12027820
[TBL] [Abstract][Full Text] [Related]
33. Surgical-pathologic risk factors and immunohistochemical markers of pelvic lymph node metastasis in stage IB1 cervical cancer.
Hernandez E; De La Mota J; Thomas MB; Huang Y; Gaughan JP; Wang F
J Low Genit Tract Dis; 2011 Oct; 15(4):303-8. PubMed ID: 21811179
[TBL] [Abstract][Full Text] [Related]
34. Can pelvic lymphadenectomy be omitted in stage IA2 to IIB uterine cervical cancer?
Togami S; Kamio M; Yanazume S; Yoshinaga M; Douchi T
Int J Gynecol Cancer; 2014 Jul; 24(6):1072-6. PubMed ID: 24905616
[TBL] [Abstract][Full Text] [Related]
35. Extended experience in the use of laparoscopic ultrasound to detect pelvic nodal metastasis in patients with cervical carcinoma.
Cheung TH; Lo WK; Yu MY; Yang WT; Ho S
Gynecol Oncol; 2004 Mar; 92(3):784-8. PubMed ID: 14984941
[TBL] [Abstract][Full Text] [Related]
36. What is the risk for parametrial involvement in women with early-stage cervical cancer with tumour <20 mm and with negative sentinel lymph nodes?
Klat J; Sevcik L; Simetka O; Graf P; Dvorackova J; Kraft O
Aust N Z J Obstet Gynaecol; 2012 Dec; 52(6):540-4. PubMed ID: 23216324
[TBL] [Abstract][Full Text] [Related]
37. Retrospective analysis for predictors of parametrial involvement in IB cervical cancer.
Kubota S; Kobayashi E; Kakuda M; Matsuzaki S; Ueda Y; Yoshino K; Kimura T
J Obstet Gynaecol Res; 2019 Mar; 45(3):679-685. PubMed ID: 30565810
[TBL] [Abstract][Full Text] [Related]
38. Prediction model of pelvic lymph node metastasis in early stage cervical cancer and its clinical value.
Sun JR; Zhang YN; Sun XM; Feng SY; Yan M
Minerva Chir; 2011 Dec; 66(6):537-45. PubMed ID: 22233660
[TBL] [Abstract][Full Text] [Related]
39. Retrospective study of pelvic and para-aortic lymph nodes positivity in stage 1A to 2A cervical cancer patients.
John Lim BB; Yong CM
Med J Malaysia; 2021 Jul; 76(4):534-540. PubMed ID: 34305115
[TBL] [Abstract][Full Text] [Related]
40. Sentinel node detection in cervical cancer with (99m)Tc-phytate.
Silva LB; Silva-Filho AL; Traiman P; Triginelli SA; de Lima CF; Siqueira CF; Barroso A; Rossi TM; Pedrosa MS; Miranda D; Melo JR
Gynecol Oncol; 2005 May; 97(2):588-95. PubMed ID: 15863164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]